Peter Craggs
Principal Laboratory Research Scientist
Pete Craggs was recruited as a Pharmacology Expert in the Crick Chemical Biology STP in September 2024. Prior to joining the Structural Biology STP, Dr. Craggs worked for GSK in early-stage drug discovery for 23 years, supporting diverse therapy areas including Immunology, Oncology, Neuroscience and Infectious Diseases. Pete received his Biochemistry BSc from the University of Newcastle-upon-Tyne in 2001 and later studied for a Structural Biology MSc at Birkbeck college, while working for GSK. Dr. Craggs studied for his PhD (again while working for GSK) in the lab of Dr. Luiz Carvalho, focusing on the enzymology of an essential TB enzyme, first at NIMR and then at the Francis Crick Institute. Following completion of PhD, Pete continued to collaborate with Dr. Carvalho, first through a fully funded GSK secondment as part of the Crick-GSK LinkLabs collaboration and then latterly via a UKRI Innovation Scholar fellowship grant. In addition, Dr. Craggs has received several grants to support his independent research, contributed to development of a number of lab instruments, worked on several drug candidates that are in clinical trials, continues to maintain collaborate with several well-known researchers including Prof. Steve Hill and has written or contributed to over 30 publications.